Dr. Zaia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 626-359-8111Fax+1 626-408-3911
Education & Training
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1970 - 1971
- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1968 - 1970
- Washington University/B-JH/SLCH ConsortiumInternship, Pediatrics, 1968 - 1969
- Harvard Medical SchoolClass of 1968
- Dartmouth CollegeB.M.Sc., 1966
- Holy Cross CollegeA.B., 1964
Certifications & Licensure
- CA State Medical License 1980 - 2025
- MA State Medical License 1970 - 2017
- GA State Medical License 1972 - 1975
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Scientific Research Portrait Gallery COH, 2010
- Chairman NIH Recombinant DNA Advisory Committee, 2010
- Aaron D. and Edith Miller Chair in Gene Therapy City of Hope, 2009
- Join now to see all
Clinical Trials
- Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant Start of enrollment: 2000 Jan 01
- Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants Start of enrollment: 2006 Dec 01
- Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer Start of enrollment: 2009 Dec 17
- Join now to see all
Publications & Presentations
PubMed
- 326 citationsCytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.Michael Boeckh, W. Garrett Nichols, Genovefa A. Papanicolaou, Robert H. Rubin, John R. Wingard
Biology of Blood and Marrow Transplantation. 2003-09-01 - 114 citationsPlasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leuk...Michael Boeckh, Ghislaine Gallez-Hawkins, David Myerson, John A. Zaia, Raleigh A. Bowden
Transplantation. 1997-07-15 - 58 citationsConsiderations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a Recombinant DNA Advisory Committee Symposium Held June 15, 2010Hildegund C.J. Ertl, John A. Zaia, Steven A. Rosenberg, Carl H. June, Gianpietro Dotti
Cancer Research. 2011-05-01
Journal Articles
- Practical Considerations in Gene Therapy for HIV CureStan R, Zaia J, Current HIV/AIDS Reports, 1/1/2014
- In Vivi Evidence Insufficient to Conclude that "KIR/HLA Incompatibility Between Sexual Partners Confers Protection Against HIV-1 Transmission"Behrendt CE, Zaia JA, Blood, 9/12/2013
- Detection and preliminary characterization of CD8 T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma Leuk LymphomaIsrayelyan A, La Rosa C, Tsai W, Kaltcheva T, Srivastava T, Aquino L, Li J, Kim Y, Palmer J, Streja L, Senitzer D, Zaia J A, Rosenwald A, Forman S J, Nakamura R, Diamo..., Leuk Lymphoma, 1/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Large-Scale Manufacturing of CMV-CD19CAR T Cells and Characterization of Their Biologic and Immunologic PropertiesJohn Zaia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Updated Analysis: Novel Machine-Learning-Based Sepsis Prediction Model for Patients Undergoing Hematopoietic Stem Cell Transplantation (Early Sepsis Prediction/Identif...John Zaia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Enhanced antitumor efficacy of adoptively transferred CD19-redirected CMV specific central memory T cells by CMV vaccine.Xiuli Wang, Winnie Wong, Wen-Chung Chang, Don Diamond, Michael C. Jensen, Christine E. Brown, John A Zaia, Stephen J. Forman, ASH, Atlanta, GA, 12/8/2012
- Join now to see all
Other
- Isolation and characterization of a 64,000 dalton polypeptide of human cytomegalovirus (CMV) using high performance liquid chromatography (HPLC).Zaia JA, Clark B, Eberle R and Ting Y-P
Cold Springs Harbor, NY - 1/1/1982 - Immunoglobulin in the prevention and treatment of viral disease. Workshop on immunological and pathological aspects of immunoglobulin prophylaxis and therapy.Levin MJ, Zaia JA, Preblud SR and Arbeit RA
Interlaken, Switzerland - 8/24/1981 - Successful immunoprophylaxis of cytomegalovirus (CMV) infection after marrow transplant with CMV immune globin (CMVig)Meyers JD, Leszczynski J, Zaia JA, Levin MJ, Snydman DR, Wright GG and Thomas ED
1/1/1981
Press Mentions
- Oldest Patient ‘Cured’ of HIV After Stem Cell Transplant from Donor with Rare Gene MutationJuly 26th, 2022
- CDC Advisers Vote in Favor of Recommending Third Vaccine Dose for Immune-ImpairedAugust 14th, 2021
- FDA Authorizes COVID-19 Vaccine Boosters for the ImmunocompromisedAugust 12th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: